Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Okada

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 7, 2007
Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Takashi Ogiyama, et al.
Nature Communications|March 25, 2016
Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3Yasuhito Yahara, Hiroshi Takemori, Minoru Okada, et al.
Sensors (Basel, Switzerland)|May 4, 2026
Semantic Communication Based on Slot Attention for MIMO Transmission in 6G Smart FactoriesNa Chen, Guijie Lin, Rubing Jian, et al.
Bioorganic & Medicinal Chemistry|October 27, 2006
Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligandsMasanori Miura, Norio Seki, Takanori Koike, et al.
Bioorganic & Medicinal Chemistry|July 3, 2007
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Ken-Ichi Kawaguchi, Hiroyuki Kaizawa, et al.
Nature Communications|June 28, 2016
Corrigendum: Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3Yasuhito Yahara, Hiroshi Takemori, Minoru Okada, et al.
Bioorganic & Medicinal Chemistry|October 20, 2006
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Ken-Ichi Kawaguchi, et al.
Annals of Medicine|October 23, 2010
Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)Aki Hiuge-Shimizu, Ken Kishida, Tohru Funahashi, et al.
Journal of Medicinal Chemistry|January 20, 2006
(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonistIsao Kinoyama, Nobuaki Taniguchi, Akira Toyoshima, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|March 7, 2007
Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Takashi Ogiyama, et al.
Nature Communications|March 25, 2016
Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3Yasuhito Yahara, Hiroshi Takemori, Minoru Okada, et al.
Sensors (Basel, Switzerland)|May 4, 2026
Semantic Communication Based on Slot Attention for MIMO Transmission in 6G Smart FactoriesNa Chen, Guijie Lin, Rubing Jian, et al.
Bioorganic & Medicinal Chemistry|October 27, 2006
Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligandsMasanori Miura, Norio Seki, Takanori Koike, et al.
Bioorganic & Medicinal Chemistry|July 3, 2007
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Ken-Ichi Kawaguchi, Hiroyuki Kaizawa, et al.
Nature Communications|June 28, 2016
Corrigendum: Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3Yasuhito Yahara, Hiroshi Takemori, Minoru Okada, et al.
Bioorganic & Medicinal Chemistry|October 20, 2006
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Ken-Ichi Kawaguchi, et al.
Annals of Medicine|October 23, 2010
Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)Aki Hiuge-Shimizu, Ken Kishida, Tohru Funahashi, et al.
Journal of Medicinal Chemistry|January 20, 2006
(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonistIsao Kinoyama, Nobuaki Taniguchi, Akira Toyoshima, et al.
Pageof 6